Company Receives Patent From Another Country for Smoking Cessation Product

Company Receives Patent From Another Country for Smoking Cessation Product

By: Dylan Sikes – AllPennyStocks.com News

Thursday, March 23, 2023

With a market size of $20 billion, there is plenty of long-term value for smoking cessation products. And this company just received patent approval in another country for its smoking cessation product.

Consumer wellness company CV Sciences, Inc. (OTCQB:CVSI) specializes in hemp extracts and other proven, science-backed, natural ingredients and products. In its press release today, the company announced that it received its formal Certificate of Grant from the Japan Patent Office for its patent application 7216697.

The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. The firm has also filed corresponding patent applications that provide similar patent protection in additional key markets, with patents already granted in the United States, Canada, Australia, Germany, Great Britain, France, Spain, Netherlands and Italy.

Shares were trading up in mid-morning trade.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Canadian Inflation Moves Up as Expected But Easing Underlying Pressures Boost Hopes of June Rate Cut
Key Executive Appointment Sends Small Cap Higher
Key Press Release Sends Small Cap Soaring Premarket
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top